CClinicalTrials.gg
CompletedNCT04034602Updated Nov 1, 2019

Immediate Effect of Plantar Vibration on Fall Risk and Postural Stability

An interventional study of vibration group and placebo group in Stroke Patients, sponsored by Kırıkkale University. Completed at 1 site in Turkey. Open to participants aged 45 Years to 75 Years. Per ClinicalTrials.gov, last updated 2019-11-01.

Sponsored by Kırıkkale University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 7 months after the study started (first participant enrolled Dec 2018, registered Jul 2019).
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
45 Years to 75 Years
Sex
All
01

Study summary

The aim of this study; To determine the immediate effect on fall risk and postural stability of vibration applied to the plantar region in stroke patients.

Read the detailed description

Kırıkkale University Faculty of Medicine Physical Therapy will be hospitalized in the USA clinic and volunteers will be involved in stroke rehabilitation. The patients who meet the inclusion criteria and who are excluded from the exclusion criteria will be randomized according to the order of arrival and will be divided into two groups as the vibration group and the placebo group.Patients will be taken to the placebo and vibration group respectively in order of arrival. If the next patient falls outside the inclusion criteria of the study, randomization will be applied to the next patient. The vibration group, one session in supine position will be applied to both sides of the soles of the feet under the soles of the feet for 5 minutes with a 15-100 Hz frequency CE certified vibration device. In the placebo group, both sides will be held in the supine position under the soles of the foot for 5 minutes each so that the device is in contact with the foot without vibration.

02

Conditions studied

  • Stroke Patients

Browse trials for

Keywords

  • stroke vibration fall risk postural stability
  • immediate effect
  • fall risk
  • postural stability
03

In context

Stroke

7,283 studies on the registry are indexed under Stroke; 2,013 are open to participants now.

This study's enrollment of 30 is below the median of 50 across 5,366 interventional studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

Kırıkkale University is the lead sponsor of 112 studies on the registry; 25 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
45 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Cognitive and non-communication problems
  • Volunteer to join the work
  • Those with less than 150 kilos
  • Spasticity according to a Modified Scale Ashworth 2 and 3 patients treated with Botox
  • Patients at least 8 weeks after stroke diagnosis

Exclusion criteria

Exclusion Criteria:

  • People who are not stable due to vital signs
  • Open wounds under the soles of the feet
  • Being spastic at the level that will block the base touch
  • Pathological conditions affecting lower limb sense (diabetic peripheral neuropathy, post- fracture surgery)
  • 20 seconds independent standing
  • Mini Mental Test score below 24
  • Multiple sclerosis, Parkinson's disease, etc.
  • Those with vision problems
  • Patients with thoracolumbar surgery
  • Patients with spinal canal stenosis
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
30 participants (actual)

Study arms

  • Experimental
    vibration group

    plantar vibration group is supine position, plantar vibration will be applied to both foot of each patient with a vibration device with a frequency of 15-100 Hz over 5 minutes.

    Other: vibration group

  • Active comparator
    placebo group

    the placebo group, both sides will be held in the supine position under the soles of the foot for 5 minutes each so that the device is in contact with the foot without vibration.

    Other: placebo group

Interventions

  • Othervibration group

    plantar vibration group is supine position, plantar vibration will be applied to both foot of each patient with a vibration device with a frequency of 15-100 Hz over 5 minutes.

  • Otherplacebo group

    the placebo group, both sides will be held in the supine position under the soles of the foot for 5 minutes each so that the device is in contact with the foot without vibration.

06

What researchers measure

Primary outcomes

  1. biodex balance system fall risk test

    Fall Risk Test is a test used to determine the risk of falling. The higher the score, the higher the risk of falling. The device compares the test results with normal age-related data to calculate the risk of falling, the platform was set to move from 12 to 8, with the platform moving. The test is carry out with 3 repetitions, each with a resting time of 10 seconds each, lasting 20 's each while the platform is static. On the support surface formed by placing the two legs in a comfortable position on the platform, it is requested to keep the black dot on the screen of the device in the middle of the visual on the screen for 20 seconds. The average of these 3 repetitions is automatically calculated by the device for the risk of falling.

    Time frame: 5 minutes

  2. biodex balance system postural stability test

    The Postural Stability Test assessment the participant's ability to control the center of gravity. The extent to which the participant's position deviates from the center is measured and reports the mean deviation as the stability index. A low score indicates that the amount of deviation is small and postural stability is good. If the standard deviation is high, the participant's postural oscillation is also high when the test platform is in a static state, each is 20 seconds lasting, between 10 seconds rest period was done as 3 repetitions. On the support surface formed by placing the two legs in a comfortable position on the platform, it was requested to keep the black dot on the screen of the device in the middle of the visual on the screen for 20 seconds. For the Mediolateral Stability Index, Anterioposterior Stability Index and General Stability Index showing the postural stability, the mean of 3 replicates of this test was automatically calculated by the device.

    Time frame: 5 minutes

07

Study locations

1 site
  • Kırıkkale University
    Kırıkkale, 71000, Turkey
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 1, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04034602
Lead sponsor
Kırıkkale University
Responsible party
Birol Önal (research assistant, Kırıkkale University) — Principal investigator
First posted
Jul 26, 2019
Start date
Dec 5, 2018
Primary completion
Jul 30, 2019
Completion
Aug 15, 2019
Last update
Nov 1, 2019

Study contacts

Birol Önal
principal investigator · Kirikkale Univercity

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion